Cart
sales@molnova.com
Casanthranol
CAS No. 8024-48-4
Casanthranol( —— )
Catalog No. M16003 CAS No. 8024-48-4
Dried aged bark of a buckthorn, Frangula purshiana (FRANGULA), that contains the anthraquinone EMODIN and cascarosides. It is used as a laxative (CATHARTICS).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 29 | In Stock |
|
| 1G | 37 | In Stock |
|
Biological Information
-
Product NameCasanthranol
-
NoteResearch use only, not for human use.
-
Brief DescriptionDried aged bark of a buckthorn, Frangula purshiana (FRANGULA), that contains the anthraquinone EMODIN and cascarosides. It is used as a laxative (CATHARTICS).
-
DescriptionDried aged bark of a buckthorn, Frangula purshiana (frangula), that contains the anthraquinone emodin and cascarosides. It is used as a laxative (cathartics).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number8024-48-4
-
Formula Weight396.58
-
Molecular FormulaC21H22O10
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C=C3[C@@H]2O[C@H]4[C@@H]([C@@H]([C@H]([C@H](O4)CO)O)O)O)CO)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Borrelli F, et al. Life Sci. 2001 Sep 7;69(16):1871-7.
molnova catalog
related products
-
Esculentoside C
Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
-
VPC-13163
VPC-13163 has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line.
-
MRT-2359
MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.
